BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 16279659)

  • 1. [Secondary hyperparathyroidism].
    Nakanishi S; Fukagawa M
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():341-6. PubMed ID: 16279659
    [No Abstract]   [Full Text] [Related]  

  • 2. [Secondary hyperparathyroidism in chronic kidney failure].
    Kalinin AP; Ivanov IA; Shcherbakova EO
    Ter Arkh; 1986; 58(8):143-8. PubMed ID: 3532407
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cell proliferation of parathyroid gland in patients with progressive secondary hyperparathyroidism: Vitamin D receptor, calcium sensing receptor, and cell cycle regulation factor].
    Tokumoto M; Taniguchi M; Matsuo D; Tsuruya K; Hirakata H; Iida M
    Clin Calcium; 2005 Sep; 15 Suppl 1():206-16. PubMed ID: 16279026
    [No Abstract]   [Full Text] [Related]  

  • 4. Roles of calcium-sensing receptor and vitamin d receptor in the pathophysiology of secondary hyperparathyroidism.
    McCann LM; Beto J
    J Ren Nutr; 2010 May; 20(3):141-50. PubMed ID: 20303786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperparathyroidism in CAPD patients: therapy with pulse oral calcitriol.
    Juergensen PH; Finkelstein FO; Cooper K; Santacroce S; Kliger AS
    Adv Perit Dial; 1993; 9():257-9. PubMed ID: 8105938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of vitamin D in the pathogenesis of renal osteodystrophy].
    Nakanishi S; Fukagawa M
    Clin Calcium; 2004 Sep; 14(9):15-20. PubMed ID: 15577104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid growth and suppression in renal failure.
    Lewin E; Huan J; Olgaard K
    Semin Dial; 2006; 19(3):238-45. PubMed ID: 16689976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Gene therapy for secondary hyperparathyroidism].
    Kanai G; Fukagawa M
    Clin Calcium; 2010 Jul; 20(7):1052-9. PubMed ID: 20585184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathogenesis of secondary hyperparathyroidism and renal bone disease].
    Ito H; Kinugasa E
    Clin Calcium; 2004 May; 14(5):720-5. PubMed ID: 15577032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term therapy with calcitriol in patients with moderate renal failure.
    Healy MD; Malluche HH; Goldstein DA; Singer FR; Massry SG
    Arch Intern Med; 1980 Aug; 140(8):1030-3. PubMed ID: 6893118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of secondary hyperparathyroidism.
    Silver J
    Nephrol Dial Transplant; 2000; 15 Suppl 5():2-7. PubMed ID: 11073267
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of intermittent treatment with sevelamer hydrochloride on parathyroid hyperplasia and vascular calcification in rats with chronic kidney disease].
    Nagano N; Miyata S; Abe M; Wakita S; Kobayashi N; Wada M
    Clin Calcium; 2005 Sep; 15 Suppl 1():35-9; discussion 39-40. PubMed ID: 16272627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regulation of the calcium-sensing receptor. Influence of secondary hyperparathyroidism].
    Fernández Martín JL; González Suárez I; Cannata Andía JB
    Nefrologia; 2003; 23 Suppl 2():7-11. PubMed ID: 12778846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperparathyroidism and renal failure.
    Arnaud CD
    Kidney Int; 1973 Aug; 4(2):89-95. PubMed ID: 4598144
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulse intravenous calcitriol therapy of secondary hyperparathyroidism in peritoneal dialysis patients.
    Wadhwa NK; Suh H; Howell N; Cabralda T; Sokunbi D; Solomon M
    Adv Perit Dial; 1993; 9():260-3. PubMed ID: 8105939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of secondary hyperparathyroidism.
    Slatopolsky E; Delmez JA
    Miner Electrolyte Metab; 1995; 21(1-3):91-6. PubMed ID: 7565472
    [No Abstract]   [Full Text] [Related]  

  • 17. [The role of calcium, calcitriol and their receptors in parathyroid regulation].
    Carrillo-López N; Fernández-Martín JL; Cannata-Andía JB
    Nefrologia; 2009; 29(2):103-8. PubMed ID: 19396314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal resistance to the calcaemic action of parathyroid hormone in uraemia: a mechanism for the hypocalcaemia and secondary hyperparathyroidism of chronic renal failure.
    Massry SG
    Clin Endocrinol (Oxf); 1976; 5 Suppl():317S-325S. PubMed ID: 1052781
    [No Abstract]   [Full Text] [Related]  

  • 19. Secondary hyperparathyroidism in chronic renal failure. Pathophysiology and treatment.
    Hanley DA; Sherwood LM
    Med Clin North Am; 1978 Nov; 62(6):1319-39. PubMed ID: 368449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid hormone and 1,25(OH)2D3 in chronic renal failure.
    Feinfeld DA; Sherwood LM
    Kidney Int; 1988 Jun; 33(6):1049-58. PubMed ID: 2841530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.